Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Attempt Gradual Dose Reductions for Psychoactive Medications

Wakefield, Nebraska Survey Completed on 07-22-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that two residents' drug regimens were free from unnecessary medications by not attempting or addressing Gradual Dose Reductions (GDRs) for their psychoactive medications. Facility policy required that behavior interventions be evaluated before using psychotropic medications, and that GDRs be attempted unless clinically contraindicated, in accordance with federal regulations. For both residents, who had diagnoses including dementia with behavioral disturbances, depression, and anxiety, there was no evidence in their medical records that GDRs were attempted or considered over the previous year for medications such as Lorazepam, Mirtazapine, Zoloft, Lexapro, and Trazadone. Record reviews showed that one resident was receiving Mirtazapine, Zoloft, and Lorazepam, while another was on Lexapro, Lorazepam, and Trazadone, with no documentation of GDRs being addressed. The Director of Nursing confirmed during interview that no GDRs had been attempted or addressed for these residents' psychoactive medications in the past year, which was inconsistent with both facility policy and regulatory requirements.

An unhandled error has occurred. Reload 🗙